XML 58 R49.htm IDEA: XBRL DOCUMENT v3.22.1
NOTE 12 - SEGMENT INFORMATION: Schedule of Segment Income (Tables)
9 Months Ended
Jan. 31, 2022
Tables/Schedules  
Schedule of Segment Income

 

 

Three Months Ended January 31,

Nine Months Ended January 31,

  

2022

2021

2022

 2021

Revenues:

 

 

 

 

Stevioside - third party

$10,890,274  

$4,125,587  

$27,053,429  

$13,146,390  

Stevioside - related party

 

2,756,224  

 

5,010,742  

Total Stevioside

10,890,274  

6,881,811  

27,053,429  

18,157,132  

 

 

 

 

 

Corporate and other – third party

107,991  

104,866  

321,420  

303,067  

Corporate and other – related party

 

 

 

 

Total Corporate and other

107,991  

104,866  

321,420  

303,067  

Total segment and consolidated revenues

$10,998,265  

$6,986,677  

$27,374,849  

$18,460,199  

Interest expense:

 

 

 

 

Stevioside

$(144,182) 

$(61,727) 

$(334,787) 

$(192,852) 

Corporate and other

 

 

 

 

Total segment and consolidated interest expense

$(144,182) 

$(61,727) 

$(334,787) 

$(192,852) 

Depreciation and amortization:

 

 

 

 

Stevioside

$332,025  

$289,361  

$955,906  

$809,215  

Corporate and other

52,642  

60,174  

165,584  

166,880  

Total segment and consolidated depreciation and amortization

$384,667  

$349,535  

$1,121,490  

$976,095  

Income (loss) from operations before income taxes:

 

 

 

 

Stevioside

$(1,615,128) 

$(1,808,789) 

$(4,369,070) 

$(3,578,716) 

Corporate and other

54,635  

47,943  

165,687  

103,592  

Total loss from continuing operations before income taxes

$(1,560,493) 

$(1,760,846) 

$(4,203,383) 

$(3,475,124)